212 related articles for article (PubMed ID: 36912192)
1. Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth.
Lemmetyinen TT; Viitala EW; Wartiovaara L; Kaprio T; Hagström J; Haglund C; Katajisto P; Wang TC; Domènech-Moreno E; Ollila S
Dis Model Mech; 2023 Apr; 16(4):. PubMed ID: 36912192
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Niche-Derived Neuregulin-1 Drives Intestinal Stem Cell Proliferation and Regeneration of Damaged Epithelium.
Jardé T; Chan WH; Rossello FJ; Kaur Kahlon T; Theocharous M; Kurian Arackal T; Flores T; Giraud M; Richards E; Chan E; Kerr G; Engel RM; Prasko M; Donoghue JF; Abe SI; Phesse TJ; Nefzger CM; McMurrick PJ; Powell DR; Daly RJ; Polo JM; Abud HE
Cell Stem Cell; 2020 Oct; 27(4):646-662.e7. PubMed ID: 32693086
[TBL] [Abstract][Full Text] [Related]
3. Epithelium-derived Indian Hedgehog restricts stromal expression of ErbB family members that drive colonic tumor cell proliferation.
Westendorp F; Karpus ON; Koelink PJ; Vermeulen JLM; Meisner S; Koster J; Büller NVJA; Wildenberg ME; Muncan V; van den Brink GR
Oncogene; 2021 Mar; 40(9):1628-1643. PubMed ID: 33479497
[TBL] [Abstract][Full Text] [Related]
4. Gene expression profiling and association studies implicate the neuregulin signaling pathway in Behçet's disease susceptibility.
Xavier JM; Krug T; Davatchi F; Shahram F; Fonseca BV; Jesus G; Barcelos F; Vedes J; Salgado M; Abdollahi BS; Nadji A; Moraes-Fontes MF; Shafiee NM; Ghaderibarmi F; Vaz Patto J; Crespo J; Oliveira SA
J Mol Med (Berl); 2013 Aug; 91(8):1013-23. PubMed ID: 23625463
[TBL] [Abstract][Full Text] [Related]
5. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer.
Gregorieff A; Liu Y; Inanlou MR; Khomchuk Y; Wrana JL
Nature; 2015 Oct; 526(7575):715-8. PubMed ID: 26503053
[TBL] [Abstract][Full Text] [Related]
6. EPIREGULIN creates a developmental niche for spatially organized human intestinal enteroids.
Childs CJ; Holloway EM; Sweet CW; Tsai YH; Wu A; Vallie A; Eiken MK; Capeling MM; Zwick RK; Palikuqi B; Trentesaux C; Wu JH; Pellón-Cardenas O; Zhang CJ; Glass I; Loebel C; Yu Q; Camp JG; Sexton JZ; Klein OD; Verzi MP; Spence JR
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36821371
[TBL] [Abstract][Full Text] [Related]
7. MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms.
Joosten SPJ; Zeilstra J; van Andel H; Mijnals RC; Zaunbrecher J; Duivenvoorden AAM; van de Wetering M; Clevers H; Spaargaren M; Pals ST
Gastroenterology; 2017 Oct; 153(4):1040-1053.e4. PubMed ID: 28716720
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor receptors and epidermal growth factor, amphiregulin and neuregulin in bovine uteroplacental tissues during gestation.
Akbalik ME; Ketani MA
Placenta; 2013 Dec; 34(12):1232-42. PubMed ID: 24138732
[TBL] [Abstract][Full Text] [Related]
9. Source and Impact of the EGF Family of Ligands on Intestinal Stem Cells.
Abud HE; Chan WH; Jardé T
Front Cell Dev Biol; 2021; 9():685665. PubMed ID: 34350179
[TBL] [Abstract][Full Text] [Related]
10. Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK.
Neufert C; Becker C; Türeci Ö; Waldner MJ; Backert I; Floh K; Atreya I; Leppkes M; Jefremow A; Vieth M; Schneider-Stock R; Klinger P; Greten FR; Threadgill DW; Sahin U; Neurath MF
J Clin Invest; 2013 Apr; 123(4):1428-43. PubMed ID: 23549083
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer.
Nagaoka T; Kitaura K; Miyata Y; Kumagai K; Kaneda G; Kanazawa H; Suzuki S; Hamada Y; Suzuki R
Mol Med Rep; 2016 Apr; 13(4):3514-20. PubMed ID: 26935861
[TBL] [Abstract][Full Text] [Related]
12. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP
Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208
[TBL] [Abstract][Full Text] [Related]
13. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Farooqui M; Bohrer LR; Brady NJ; Chuntova P; Kemp SE; Wardwell CT; Nelson AC; Schwertfeger KL
Mol Cancer; 2015 Jul; 14():138. PubMed ID: 26215578
[TBL] [Abstract][Full Text] [Related]
14. NRG1 and NRG2 fusion positive solid tumor malignancies: a paradigm of ligand-fusion oncogenesis.
Nagasaka M; Ou SI
Trends Cancer; 2022 Mar; 8(3):242-258. PubMed ID: 34996744
[TBL] [Abstract][Full Text] [Related]
15. Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenografts.
Sarup J; Jin P; Turin L; Bai X; Beryt M; Brdlik C; Higaki JN; Jorgensen B; Lau FW; Lindley P; Liu J; Ni I; Rozzelle J; Kumari R; Watson SA; Zhang J; Shepard HM
Mol Cancer Ther; 2008 Oct; 7(10):3223-36. PubMed ID: 18852126
[TBL] [Abstract][Full Text] [Related]
16. LH-induced neuregulin 1 (NRG1) type III transcripts control granulosa cell differentiation and oocyte maturation.
Noma N; Kawashima I; Fan HY; Fujita Y; Kawai T; Tomoda Y; Mihara T; Richards JS; Shimada M
Mol Endocrinol; 2011 Jan; 25(1):104-16. PubMed ID: 21047912
[TBL] [Abstract][Full Text] [Related]
17. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of the EGF-like domain of neuregulin-1 to integrins ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB signaling.
Ieguchi K; Fujita M; Ma Z; Davari P; Taniguchi Y; Sekiguchi K; Wang B; Takada YK; Takada Y
J Biol Chem; 2010 Oct; 285(41):31388-98. PubMed ID: 20682778
[TBL] [Abstract][Full Text] [Related]
19. Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer.
Ogier C; Colombo PE; Bousquet C; Canterel-Thouennon L; Sicard P; Garambois V; Thomas G; Gaborit N; Jarlier M; Pirot N; Pugnière M; Vie N; Gongora C; Martineau P; Robert B; Pèlegrin A; Chardès T; Larbouret C
Cancer Lett; 2018 Sep; 432():227-236. PubMed ID: 29935372
[TBL] [Abstract][Full Text] [Related]
20. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor.
Bade LK; Goldberg JE; Dehut HA; Hall MK; Schwertfeger KL
J Cell Sci; 2011 Sep; 124(Pt 18):3106-17. PubMed ID: 21868365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
